XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB)

CUSIP: 98386D307

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class
Equity / SPONSORED ADR NE
Total 13F shares
0
Total 13F value
$0
Share change
-329,727
SEC-reported price per share
$0.58
Number of holders
0
Value change
-$190,883
Number of sells
6

Security key

98386D307

Report period

Q1 2026

Institutions

0

Top holders

0

XTLB full security history Previous quarter: Q4 2025 XTL BIOPHARMACEUTICALS LTD SEC filings XTL BIOPHARMACEUTICALS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

There are no holders of XTLB - XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE as of Q1 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .